Luye Pharma Group (OTCMKTS:LYPHF) Rating Increased to Neutral at Credit Suisse Group
Luye Pharma Group (OTCMKTS:LYPHF) Rating Increased to Neutral at Credit Suisse Group
瑞士信貸集團的綠葉製藥集團（OTCMKTS: LYPHF）評級提高至中性
Luye Pharma Group (OTCMKTS:LYPHF – Get Rating) was upgraded by Credit Suisse Group from an "underperform" rating to a "neutral" rating in a research note issued on Wednesday, The Fly reports.
綠葉製藥集團（OTCMKTS: LYPHF — 獲取評級） The Fly報道，瑞士信貸集團在週三發佈的一份研究報告中將評級從 “表現不佳” 上調至 “中性”。
Luye Pharma Group Price Performance
綠葉製藥集團價格表現
Shares of LYPHF stock opened at $0.75 on Wednesday.
週三，LYPHF股票開盤價爲0.75美元。
Get
獲取
Luye Pharma Group
綠葉製藥集團
alerts:
警報：
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Luye Pharma Group (LYPHF)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
- 免費獲取 StockNews.com 關於綠葉製藥集團（LYPHF）的研究報告的副本
- Hypercharge Networks：上漲了三位數，但有甚麼大不了的？
- 蘋果30％的漲勢有長足的3個原因
- 選擇原住民而不是第一共和國銀行的3個理由
- 4月3日財報爲看漲的波段交易者帶來了樂觀
- 星座品牌之星即將崛起嗎？
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
接收綠葉製藥集團日報的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收綠葉製藥集團及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。